A detailed history of Cm Management, LLC transactions in Bio Cardia, Inc. stock. As of the latest transaction made, Cm Management, LLC holds 700,000 shares of BCDA stock, worth $2.06 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
700,000
Previous 700,000 -0.0%
Holding current value
$2.06 Million
Previous $462,000 37.88%
% of portfolio
0.25%
Previous 0.38%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$0.37 - $1.07 $37,000 - $107,000
100,000 Added 16.67%
700,000 $462,000
Q3 2023

Nov 07, 2023

BUY
$0.37 - $2.85 $95,090 - $732,450
257,000 Added 74.93%
600,000 $258,000
Q2 2023

Aug 04, 2023

BUY
$1.52 - $2.8 $21,280 - $39,200
14,000 Added 4.26%
343,000 $916,000
Q2 2021

Aug 10, 2021

BUY
N/A
15,900 Added 5.08%
329,000 $1.31 Million
Q1 2021

May 12, 2021

BUY
N/A
83,100 Added 36.13%
313,100 $1.36 Million
Q4 2020

Feb 04, 2021

BUY
N/A
230,000 New
230,000 $796,000

Others Institutions Holding BCDA

About BioCardia, Inc.


  • Ticker BCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,758,200
  • Market Cap $52.2M
  • Description
  • BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...
More about BCDA
Track This Portfolio

Track Cm Management, LLC Portfolio

Follow Cm Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cm Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cm Management, LLC with notifications on news.